Lisa F. Akiyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisa F. Akiyama has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Brittany N. Sprigg
Division of Pediatric Neurology, Department of Neurology, University of California San Diego, San Diego, California
1 shared publicationDeniz Atilgan
Department of Neurology University of Texas Health Science Center at Houston Houston Texas USA
1 shared publicationDwight Barry
Clinical Analytics, Seattle Children's Hospital, Seattle, Washington
1 shared publicationEdward J. Novotny
Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
1 shared publicationHyoung Won Choi
Division of Neurology, Department of Pediatrics Emory University Atlanta Georgia USA
1 shared publication- Jacqueline A. French
Comprehensive Epilepsy Center New York University Grossman School of Medicine New York New York USA
1 shared publication
Latest Publications
- 8 January 2024
- Published by Elsevier in Pediatric Neurology
- Vol. 152, 169-176
Reducing Time to Electroencephalography in Pediatric Convulsive Status Epilepticus: A Quality Improvement Initiative
- 8 January 2024
- Published by Elsevier in Pediatric Neurology
- Vol. 152, 169-176
Reducing Time to Electroencephalography in Pediatric Convulsive Status Epilepticus: A Quality Improvement Initiative
- Open Access
Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference
Substantial efforts are underway toward optimizing the diagnosis, monitoring, and treatment of seizures and epilepsy. We describe preclinical programs in place for screening investigational therapeutic candidates in animal models, with particular attention to identifying and eliminating drugs that might paradoxically aggravate seizure burden. After preclinical development, we discuss challenges and solutions in the design and regulatory logistics of clinical trial execution, and efforts to develop disease biomarkers and interventions that may be not only seizure‐suppressing, but also disease‐modifying. As disease‐modifying treatments are designed, there is clear recognition that, although seizures represent one critical therapeutic target, targeting nonseizure outcomes like cognitive development or functional outcomes requires changes to traditional designs. This reflects our increasing understanding that epilepsy is a disease with profound impact on quality of life for the patient and caregivers due to both seizures themselves and other nonseizure factors. This review examines selected key challenges and future directions in epilepsy diagnostics and therapeutics, from drug discovery to translational application.
Open AccessChallenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference
Substantial efforts are underway toward optimizing the diagnosis, monitoring, and treatment of seizures and epilepsy. We describe preclinical programs in place for screening investigational therapeutic candidates in animal models, with particular attention to identifying and eliminating drugs that might paradoxically aggravate seizure burden. After preclinical development, we discuss challenges and solutions in the design and regulatory logistics of clinical trial execution, and efforts to develop disease biomarkers and interventions that may be not only seizure‐suppressing, but also disease‐modifying. As disease‐modifying treatments are designed, there is clear recognition that, although seizures represent one critical therapeutic target, targeting nonseizure outcomes like cognitive development or functional outcomes requires changes to traditional designs. This reflects our increasing understanding that epilepsy is a disease with profound impact on quality of life for the patient and caregivers due to both seizures themselves and other nonseizure factors. This review examines selected key challenges and future directions in epilepsy diagnostics and therapeutics, from drug discovery to translational application.
- 1 January 2011
- Published by Elsevier in Neuroscience Letters
- Vol. 488 (2) , 183-187
Automatic cortical responses to sound movement: A magnetoencephalography study
- 1 January 2011
- Published by Elsevier in Neuroscience Letters
- Vol. 488 (2) , 183-187
Automatic cortical responses to sound movement: A magnetoencephalography study